Arzeda Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Arzeda Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10855
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arzeda Corp (Arzeda) is a biotechnology company that develops biological solutions for transformative products. The company’s products include novel crop traits, 1, 3-butadiene, levulinic acid, and methane. Its services comprise enzyme design, metabolic engineering, and protein optimization services. Arzeda utilizes natural environments for bulk synthesis that carries manufacture of important universal industrial building blocks such as butanol, isoprene or adipic acid; and potential to create building block precursors with different properties. The company designs cell factories for producing specialty and bulk chemicals. Its products are used for improvement of both crop yields and farming resource efficiency. The company partners with agriculture and biotech partners to develop novel products. Arzeda is headquartered in Seattle, Washington, the US.

Arzeda Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arzeda Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Arzeda Corp, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Arzeda Raises Additional USD3.2 Million in Series A Financing 9
Arzeda Raises USD12 Million in Series A Financing 10
Partnerships 11
Zymergen Enters into Co-Development Agreement with Arzeda 11
Arzeda Corp – Key Competitors 12
Arzeda Corp – Key Employees 13
Arzeda Corp – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Corporate Communications 15
Dec 21, 2017: Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Arzeda Corp, Pharmaceuticals & Healthcare, Key Facts 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arzeda Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Arzeda Raises Additional USD3.2 Million in Series A Financing 9
Arzeda Raises USD12 Million in Series A Financing 10
Zymergen Enters into Co-Development Agreement with Arzeda 11
Arzeda Corp, Key Competitors 12
Arzeda Corp, Key Employees 13

List of Figures
Arzeda Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arzeda Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Arzeda Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caledonia Investments plc:企業の戦略・SWOT・財務情報
    Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report Summary Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • FXI, Inc.:企業の戦略的SWOT分析
    FXI, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Luby’s Inc.の企業概要及び財務/SWOT分析
    Luby’s Inc. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Luby’s Inc. annual and quarterly forecasts made by stock market experts. The report also enables direct comparison …
  • VU University Medical Center(製薬・医療分野):企業M&A動向
    Summary VU University Medical Center (VUMC) is a healthcare center. The center provides patient care services for diagnosis and treatment of disease and injury. It offers services such as care, research, training, and educational programs. VUMC’s departments include adult intensive care, anesthesiol …
  • Lime Energy Co.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lime Energy Co. Mergers and Acq …
  • ARCA biopharma Inc (ABIO):企業の財務・戦略的SWOT分析
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • JSC Severstal Metiz:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC Severstal Metiz Mergers and …
  • One Lambda, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary One Lambda, Inc. (One Lambda), a subsidiary of Thermo Fisher Scientific Inc., is a medical equipment company that develops and distributes histocompatibility typing tests and antibody detection products. The company offers products such as HLA tissue typing trays, monoclonal typing trays, ce …
  • GE Consumer & Industrial:企業の戦略的SWOT分析
    GE Consumer & Industrial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hotel Royal Limited:企業の戦略・SWOT・財務情報
    Hotel Royal Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Royal Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NAVTEQ Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NAVTEQ Corporation Mergers and …
  • Difference Capital Financial Inc.:企業のM&A・提携・投資分析
    Difference Capital Financial Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Difference Capital Financial Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Visible Measures Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Visible Measures Corp. Mergers …
  • Egdon Resources Plc (Formerly New Egdon plc):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Egdon Resources Plc (Formerly N …
  • AOL LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AOL LLC Mergers and Acquisition …
  • Numab Innovation AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Numab Innovation AG (Numab) is a developer of novel therapeutics for the treatment of severe diseases. The company’s pipeline products include ND007, ND009, ND016, ND017, ND023, ND026, and ND021. Its ND007 is a bispecific antibody fragment which is being evaluated for the treatment of autoim …
  • Wood Group Mustang Inc-石油・ガス分野:企業M&A・提携分析
    Summary Wood Group Mustang, Inc. (Wood Group Mustang), a subsidiary of John Wood Group PLC is an engineering management company. It provides engineering, procurement, and construction management (EPC) services to clients across diverse end markets. The company’s service portfolio comprises design an …
  • Grupo Aeroportuario del Pacífico, S.A.B. de C.V.:企業の戦略・SWOT・財務分析
    SummaryGrupo Aeroportuario del Pacífico, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ …
  • Jordan Health Services Inc-製薬・医療分野:企業M&A・提携分析
    Summary Jordan Health Services Inc (Jordan) is a healthcare service provider that offers home healthcare services. The center offers personal care services, home management, pediatric services, skilled care and hospice services. It provides pediatric programs which include comprehensive care program …
  • CSI Compressco LP (CCLP):石油・ガス:M&Aディール及び事業提携情報
    Summary CSI Compressco LP (CSI), formerly Compressco Partners LP, a subsidiary of TETRA Technologies Inc, is an oilfield consulting company that offers compression services and equipment for natural gas and oil production, transportation, and storage. The company's products include real-time compres …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆